Nutraceutical Emulsion for Cognitive Support and Easy Swallowing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nutraceuticals and supplements fail to comprehensively address cognitive impairment and Alzheimer's disease by lacking a combination of antioxidant, anti-inflammatory, and metabolic mechanisms, and are unsuitable for elderly individuals with swallowing difficulties, with poor bioavailability and stability issues.
Innovation Solution
A nutraceutical emulsion comprising Piper nigrum, Theobroma cacao, Plukenetia volubilis oil, and other natural extracts, formulated to provide a stable, easily swallowable source of medium-chain fatty acids, antioxidants, and anti-inflammatory compounds, promoting neuronal health and cognitive function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional nutraceuticals are used, then cognitive impairment is addressed, but bioavailability and stability are poor
Solution Approach 1:
The patent transforms the physical and chemical parameters of the nutraceutical components by converting them into an emulsion form. This involves changing the state of matter from separate phases to a stabilized emulsion, which significantly improves bioavailability and stability while maintaining the cognitive benefits of the active ingredients
Solution Approach 2:
The patent creates a composite emulsion system that combines multiple nutraceutical components (medium-chain triglycerides, antioxidants, anti-inflammatory compounds) with emulsifying agents. This composite structure allows for enhanced delivery and absorption of the active substances, resolving the bioavailability issue while preserving their cognitive protective effects
2Reliability
If conventional supplements are used, then cognitive function is targeted, but they are unsuitable for elderly with swallowing difficulties
Solution Approach 1:
The patent changes the physical form and texture parameters of the nutraceutical delivery system by creating a smooth emulsion consistency. This transformed state is easily swallowable for elderly individuals while still delivering the full cognitive benefits of the active ingredients, eliminating the need for complex dosing regimens
3Reliability
If comprehensive mechanisms are implemented, then cognitive impairment is effectively treated, but device complexity increases
Solution Approach 1:
The patent merges multiple therapeutic mechanisms (antioxidant, anti-inflammatory, metabolic support) into a single integrated emulsion formulation. By combining these functions into one unified product, the patent achieves comprehensive coverage of cognitive impairment mechanisms while simplifying the user experience, as elderly individuals only need to take one product rather than multiple separate supplements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The emulsion demonstrates significant cognitive improvement in aged mice, comparable to young mice, with improved bioavailability and stability, addressing multiple disease mechanisms and suitable for elderly individuals.
Implementation Method 1
Medium-chain triglycerides (MCTG), constitute an alternative source of energy in the absence of glucose for the cells. In this context, ketone bodies, which are produced from medium chain triglycerides (MCTG), constitute an alternative source of energy
Implementation Method 2
Oxidative stress is also induced in the neuron, which causes an alteration in calcium ion homeostasis
Implementation Method 3
This action causes the release of cytokines or components of the complement system, leading to inflammatory responses
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The present invention consists of a solid nutraceutical composition for preventing and treating cognitive impairment, composed of a mixture of an emulsion and a mass of seeds and oil whose components are of natural origin. The emulsion contains Plukenetia volubilis oil, extracts of vegetable origin such as Curcuma longa, Piper nigrum or Theobroma cacao, emulsifiers selected among lecithin, Saponaria or Agavaceae extract, or egg white, edulcorants selected among fructooligosaccharide, Stevia rebaudiana or Agavaceae extract, Apis mellifera, sucrose, and also contains air. The mass of seeds and oil includes Cucurbita seeds and Plukenetia volubilis oil. Other components selected from Theobroma cocoa powder, Cocos nucifera oil, fruit or seed mass, natural juices and proteins are added. Thus, the nutraceutical is composed of 3 to 5 sources of fatty acids, phytosterols and triacylglycerols, 2 to 8 sources of antioxidants, up to 3 sources of hypoglycemic agents, up to 4 sources of anti-cholesterol and anti-inflammatory compounds. It also contains proteins, vitamins, macro- and microelements, and substances that enable easy chewing and swallowing suitable for subjects and patients suffering from cognitive deficits. The nutraceutical is appropriate for the prevention and treatment of Alzheimer's disease, mental, behavioral and developmental disorders, including depressive disorders and disorders of the nervous, digestive, immune, endocrine and circulatory systems, cardiovascular, cerebrovascular, infectious, parasitic, oncological and blood diseases, tiredness, fatigue and malnutrition.